What's in Christopher J. McLeod's pipeline?

Christopher J. McLeod has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Christopher J. McLeod's portfolio?

Top competitors by shared drug class: ANRS, Emerging Infectious Diseases, ASST Fatebenefratelli Sacco, Bamrasnaradura Infectious Diseases Institute, French National Agency for Research on AIDS and Viral Hepatitis, Hoffmann-La Roche.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/christopher-j-mcleod.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

Christopher J. McLeod — Portfolio Competitive Intelligence Brief

Christopher J. McLeod pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
PEP	PEP	marketed	Protease inhibitor	HIV protease	Infectious disease

Therapeutic area mix

Infectious disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ANRS, Emerging Infectious Diseases · 1 shared drug class
ASST Fatebenefratelli Sacco · 1 shared drug class
Bamrasnaradura Infectious Diseases Institute · 1 shared drug class
French National Agency for Research on AIDS and Viral Hepatitis · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
Janssen R&D Ireland · 1 shared drug class
Janssen-Cilag International NV · 1 shared drug class
Johns Hopkins University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Christopher J. McLeod:

Cite this brief

Drug Landscape (2026). Christopher J. McLeod — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/christopher-j-mcleod. Accessed 2026-05-15.